These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9160270)

  • 1. An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Ritter MA; Furtek CI; Lo MW
    J Pharm Biomed Anal; 1997 Apr; 15(7):1021-9. PubMed ID: 9160270
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry.
    Polinko M; Riffel K; Song H; Lo MW
    J Pharm Biomed Anal; 2003 Sep; 33(1):73-84. PubMed ID: 12946533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
    Furtek CI; Lo MW
    J Chromatogr; 1992 Jan; 573(2):295-301. PubMed ID: 1601963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
    Farthing D; Sica D; Fakhry I; Pedro A; Gehr TW
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):374-8. PubMed ID: 9518174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of a new potent angiotensin II receptor antagonist, TCV-116, and its metabolites in human serum and urine.
    Miyabayashi T; Okuda T; Motohashi M; Izawa K; Yashiki T
    J Chromatogr B Biomed Appl; 1996 Feb; 677(1):123-32. PubMed ID: 8925084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats.
    Soldner A; Spahn-Langguth H; Mutschler E
    J Pharm Biomed Anal; 1998 Jan; 16(5):863-73. PubMed ID: 9535198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar tablets.
    Williams RC; Alasandro MS; Fasone VL; Boucher RJ; Edwards JF
    J Pharm Biomed Anal; 1996 Aug; 14(11):1539-46. PubMed ID: 8877861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection.
    Stenhoff H; Lagerström PO; Andersen C
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):411-7. PubMed ID: 10510797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method.
    Ferreirós N; Iriarte G; Alonso RM; Jiménez RM; Ortíz E
    J Sep Sci; 2008 Mar; 31(4):667-76. PubMed ID: 18307163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
    Ohtawa M; Takayama F; Saitoh K; Yoshinaga T; Nakashima M
    Br J Clin Pharmacol; 1993 Mar; 35(3):290-7. PubMed ID: 8471405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pK(a) determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry.
    Cagigal E; González L; Alonso RM; Jiménez RM
    J Pharm Biomed Anal; 2001 Oct; 26(3):477-86. PubMed ID: 11489393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine. I. DuP 532 (L-694,492).
    Chiou RH; Lo MW
    J Chromatogr; 1992 Oct; 581(1):165-70. PubMed ID: 1430003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.
    Yeung PK; Jamieson A; Smith GJ; Fice D; Pollak PT
    Int J Pharm; 2000 Aug; 204(1-2):17-22. PubMed ID: 11011981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
    Wong PC; Christ DD; Wong YN; Lam GN
    Pharmacology; 1996 Jan; 52(1):25-9. PubMed ID: 8966199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
    Liu D; Jiang J; Wang P; Feng S; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):743-8. PubMed ID: 20153270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
    Lo MW; Goldberg MR; McCrea JB; Lu H; Furtek CI; Bjornsson TD
    Clin Pharmacol Ther; 1995 Dec; 58(6):641-9. PubMed ID: 8529329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats.
    Liu AC; Zhao LX; Xing J; Liu T; Du FY; Lou HX
    Biol Pharm Bull; 2012; 35(2):145-50. PubMed ID: 22293343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of column-switching high-performance liquid chromatographic methods for the determination of a potent AII receptor antagonist, TCV-116, and its metabolites in human serum and urine.
    Lee JW; Naidong W; Johnson T; Dzerk A; Miyabayashi T; Motohashi M
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):287-98. PubMed ID: 8548019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry.
    Iwasa T; Takano T; Hara K; Kamei T
    J Chromatogr B Biomed Sci Appl; 1999 Nov; 734(2):325-30. PubMed ID: 10595730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.